Biotechnology

Cambridge, U.K.-based Broken String Biosciences launched BaseMap ABE, built on the company’s INDUCE-seq® technology, to support adenine base editing (ABE) applications. Base editing is gaining momentum as a powerful therapeutic tool that enables precise single-base...

The Gates Foundation awarded a $500,000 Grand Challenges grant to a University of Connecticut (UConn) researcher specializing in the development and commercialization of sustainable food products using algae and other natural materials. A photo of...

Neck and back pain could be caused by changes in gene activity that trigger the breakdown of the spine’s natural shock absorbers, according to researchers in the U.K. Findings from a study in zebrafish,...

Read Now<img decoding="async" src="https://www.genengnews.com/wp-content/uploads/2026/08/2607_Nautilus_eBook_Cover-232x300.jpg" alt="Tau andAlzheimer’sDisease eBook cover” class=”wp-image-336117″/>The last few decades have seen rapid advances in Alzheimer’s disease (AD) research. From the development of new brain imaging methods to novel biomarkers, to the...

Sponsored content brought to you by In today’s biopharmaceutical industry, success is no longer defined by how much therapeutic antibody you can produce, but by how well you can purify it. As upstream systems generate...

CDMO Enzene launched NeX, which it labels “an end-to-end partnership model that enables governments, institutions, and biopharma organizations to establish world-class biomanufacturing capabilities wherever they need them.” NeX, built on the EnzeneX® continuous manufacturing (FCCM)...

Artificial intelligence readiness involves much more than upgrading technology. For laboratories operating in regulated environments, it requires connected workflows, trusted data, effective human oversight, and compliance built into systems from the outset. Fragmented processes...

Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow. Sethera will generate and experimentally screen architecture-diverse polymacrocyclic peptide libraries. Receptor.AI will apply physics-based modeling, artificial intelligence, and multiparameter optimization to interpret sequence,...

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans to do so on the Hong Kong Exchange rather than...

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models is the provision of its integrated AI drug discovery platform,...